Search

everythinglearnresearchcommunity

for

Search:↓

Platelet Rich Plasma (PRP) shows promise for hair growth, ulcer healing, and skin rejuvenation, but more research is needed for consistent results and it's not suitable for people with certain blood conditions.

PRP therapy with a derma roller is a safe and effective treatment for female hair loss.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The package offers tools for exploring potential miRNA changes in female hair loss.

PRP derivatives are likely safe for therapeutic use without harmful effects.

BAF200 is essential for proper heart and coronary artery formation.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Finasteride may help treat Neutrophil Actin Dysfunction by reducing LSP1 gene activity.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

A PRP concentration of 1.0 × 10^6 plt/μL is best for tissue repair.

Forensic DNA phenotyping can now predict more physical traits and ancestry from DNA, but further improvements are needed.

Nerve growth factor helps cashmere goat hair cells grow by activating a specific protein.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

Using L-PRF membranes for skull base surgery might help healing, but more research is needed.

Krt6a-Cre transgenic mice help study gene effects on hair follicle development and tumor suppression.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Combining Endo-RF with PRP may improve acne scars better than Endo-RF alone.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

Platelet-rich plasma (PRP) treatments are not effective.

PRP's benefits for treating scarring hair loss are still uncertain.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Scientists created a detailed map of gene activity in different parts of human hair follicles.

The androgen receptor gene doesn't affect women with recurrent spontaneous abortions, but having a mutant genotype might protect against it.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Injecting platelet-derived growth factors into ovaries may improve IVF outcomes by enhancing egg quality and embryo health.

A legally valid consent form for PRP injections was created to improve communication and protect against lawsuits.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.